S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.58 (+0.05%)
AAPL   141.63 (+1.84%)
MSFT   226.34 (+0.17%)
FB   275.04 (+0.20%)
GOOGL   1,871.52 (-1.11%)
AMZN   3,281.00 (-0.34%)
TSLA   865.81 (+2.26%)
NVDA   538.17 (-1.88%)
BABA   259.60 (+0.38%)
CGC   32.77 (-3.05%)
GE   10.88 (-2.07%)
MU   79.73 (-3.10%)
AMD   92.83 (+0.04%)
NIO   59.94 (-3.24%)
T   28.85 (-0.28%)
F   10.99 (-4.60%)
ACB   10.16 (-4.60%)
BA   200.46 (-2.61%)
DIS   170.23 (-1.48%)
NFLX   556.14 (-1.60%)
GILD   67.01 (+0.10%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.58 (+0.05%)
AAPL   141.63 (+1.84%)
MSFT   226.34 (+0.17%)
FB   275.04 (+0.20%)
GOOGL   1,871.52 (-1.11%)
AMZN   3,281.00 (-0.34%)
TSLA   865.81 (+2.26%)
NVDA   538.17 (-1.88%)
BABA   259.60 (+0.38%)
CGC   32.77 (-3.05%)
GE   10.88 (-2.07%)
MU   79.73 (-3.10%)
AMD   92.83 (+0.04%)
NIO   59.94 (-3.24%)
T   28.85 (-0.28%)
F   10.99 (-4.60%)
ACB   10.16 (-4.60%)
BA   200.46 (-2.61%)
DIS   170.23 (-1.48%)
NFLX   556.14 (-1.60%)
GILD   67.01 (+0.10%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.58 (+0.05%)
AAPL   141.63 (+1.84%)
MSFT   226.34 (+0.17%)
FB   275.04 (+0.20%)
GOOGL   1,871.52 (-1.11%)
AMZN   3,281.00 (-0.34%)
TSLA   865.81 (+2.26%)
NVDA   538.17 (-1.88%)
BABA   259.60 (+0.38%)
CGC   32.77 (-3.05%)
GE   10.88 (-2.07%)
MU   79.73 (-3.10%)
AMD   92.83 (+0.04%)
NIO   59.94 (-3.24%)
T   28.85 (-0.28%)
F   10.99 (-4.60%)
ACB   10.16 (-4.60%)
BA   200.46 (-2.61%)
DIS   170.23 (-1.48%)
NFLX   556.14 (-1.60%)
GILD   67.01 (+0.10%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.58 (+0.05%)
AAPL   141.63 (+1.84%)
MSFT   226.34 (+0.17%)
FB   275.04 (+0.20%)
GOOGL   1,871.52 (-1.11%)
AMZN   3,281.00 (-0.34%)
TSLA   865.81 (+2.26%)
NVDA   538.17 (-1.88%)
BABA   259.60 (+0.38%)
CGC   32.77 (-3.05%)
GE   10.88 (-2.07%)
MU   79.73 (-3.10%)
AMD   92.83 (+0.04%)
NIO   59.94 (-3.24%)
T   28.85 (-0.28%)
F   10.99 (-4.60%)
ACB   10.16 (-4.60%)
BA   200.46 (-2.61%)
DIS   170.23 (-1.48%)
NFLX   556.14 (-1.60%)
GILD   67.01 (+0.10%)
Log in
LON:COS

Collagen Solutions plc (COS.L) Share Forecast, Price & News

GBX 6.62
0.00 (0.00 %)
(As of 11/16/2020)
Add
Compare
Today's Range
6.63
Now: GBX 6.63▼
6.63
50-Day Range
6.63
MA: GBX 6.62▼
6.63
52-Week Range
0.70
Now: GBX 6.63▼
6.95
Volume15,000 shs
Average Volume298,181 shs
Market Capitalization£30.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.

MarketRank™

Overall MarketRank™

0.58 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolLON:COS
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.collagensolutions.com
Phone+44-141-6489100
Employees48
Year FoundedN/A

Debt

Debt-to-Equity Ratio7.49
Current Ratio1.24
Quick Ratio1.10

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales£4.01 million
Price / Sales7.73
Cash FlowGBX 0.50 per share
Price / Cash Flow13.25
Book ValueGBX 4 per share
Price / Book1.66

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares467,830,016
Market Cap£30.99 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 6.62
0.00 (0.00 %)
(As of 11/16/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive COS News and Ratings via Email

Sign-up to receive the latest news and ratings for COS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Collagen Solutions plc (COS.L) (LON:COS) Frequently Asked Questions

How has Collagen Solutions plc (COS.L)'s stock been impacted by Coronavirus?

Collagen Solutions plc (COS.L)'s stock was trading at GBX 2.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, COS shares have increased by 201.1% and is now trading at GBX 6.63.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Collagen Solutions plc (COS.L)?

Wall Street analysts have given Collagen Solutions plc (COS.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Collagen Solutions plc (COS.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Collagen Solutions plc (COS.L)'s earnings last quarter?

Collagen Solutions plc (COS.L) (LON:COS) announced its earnings results on Friday, July, 31st. The company reported ($0.76) earnings per share (EPS) for the quarter.
View Collagen Solutions plc (COS.L)'s earnings history.

Who are some of Collagen Solutions plc (COS.L)'s key competitors?

Some companies that are related to Collagen Solutions plc (COS.L) include Antibe Therapeutics Inc. (ATE.V) (ATE), Verona Pharma plc (VRP.L) (VRP), Circassia Group Plc (CIR.L) (CIR), Acasti Pharma Inc. (ACST.V) (ACST), e-therapeutics plc (ETX.L) (ETX), Novoheart (NVH), OKYO Pharma Limited (OKYO.L) (OKYO), Oxford BioDynamics Plc (OBD.L) (OBD), C4X Discovery Holdings plc (C4XD.L) (C4XD), Agronomics Limited (ANIC.L) (ANIC), Annovis Bio (ANVS), ReNeuron Group plc (RENE.L) (RENE), Destiny Pharma plc (DEST.L) (DEST), Pediapharm Inc. (PDP.V) (PDP) and Sirona Biochem Corp. (SBM.V) (SBM).
View all of COS's competitors.

What other stocks do shareholders of Collagen Solutions plc (COS.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Collagen Solutions plc (COS.L) investors own include ReNeuron Group plc (RENE.L) (RENE), Sareum Holdings plc (SAR.L) (SAR), Oxford Biomedica plc (OXB.L) (OXB), ValiRx plc (VAL.L) (VAL), Active Energy Group PLC (AEG.L) (AEG), Norcros plc (NXR.L) (NXR), Oxford Instruments plc (OXIG.L) (OXIG), Proteome Sciences plc (PRM.L) (PRM), Perseus Mining Limited (PRU.TO) (PRU) and Nektar Therapeutics (NKTR).

Who are Collagen Solutions plc (COS.L)'s key executives?

Collagen Solutions plc (COS.L)'s management team includes the following people:
  • Mr. Jamal D. Rushdy, CEO & Director (Age 48, Pay $243.5k)
  • Ms. Hilary G. Spence, CFO, Company Sec. & Director
  • Mr. Tom Hyland, Chief Technical Adviser (Age 55, Pay $72.1k)
  • Dr. John Higgins, Chief Technology Officer
  • Ms. Lisa Baderoon, Head of Investor Relations
  • Mr. Brad Selman, VP of Global Sales & Marketing
  • Ms. Diane Mitchell MBA, Chief Commercial Officer
  • Mr. Kevin Darling, VP of Tissue Products & MD of New Zealand
  • Ms. Gillian Nancy Black, Company Sec. (Age 57)
  • Dr. Stewart White Ph.D., MBA, Consultant & Member of Scientific Advisory Board (Age 49)

What is Collagen Solutions plc (COS.L)'s stock symbol?

Collagen Solutions plc (COS.L) trades on the London Stock Exchange (LON) under the ticker symbol "COS."

How do I buy shares of Collagen Solutions plc (COS.L)?

Shares of COS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Collagen Solutions plc (COS.L)'s stock price today?

One share of COS stock can currently be purchased for approximately GBX 6.63.

How big of a company is Collagen Solutions plc (COS.L)?

Collagen Solutions plc (COS.L) has a market capitalization of £30.99 million and generates £4.01 million in revenue each year. Collagen Solutions plc (COS.L) employs 48 workers across the globe.

What is Collagen Solutions plc (COS.L)'s official website?

The official website for Collagen Solutions plc (COS.L) is www.collagensolutions.com.

How can I contact Collagen Solutions plc (COS.L)?

Collagen Solutions plc (COS.L)'s mailing address is Nova Business Park, 3 Robroyston Oval, GLASGOW, G33 1AP, United Kingdom. The company can be reached via phone at +44-141-6489100.

This page was last updated on 1/25/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.